Back to search

Article

Prognostic and Predictive Value of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutant Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors: A Single-Center Retrospective Study with Subgroup Analysis of 19del vs. L858R

2026-04-02

Abstract excerpt

<title>Abstract</title> <p>Background Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are the standard first-line treatment for EGFR-mutant lung adenocarcinoma. However, the efficacy and prognosis vary significantly among individuals. This study aimed to investigate the correlation between baseline 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) me...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3e8600de-adc1-592a-bebc-e01a6d8dce1d
DOI
10.21203/rs.3.rs-9240616/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic and Predictive Value of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutant Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors: A Single-Center Retrospective Study with Subgroup Analysis of 19del vs. L858RDOI 10.21203/rs.3.rs-9240616/v1
Select a neighboring publication to make it the new centre.